ARG
Vaso-occlusive Pain Episode
Emory UniversitySmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Vaso-occlusive Pain Episode cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
L-Citrulline Suvankar Majumdar | Phase 2 | CCC |
Same molecule, other indications
ARG is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →